CENCORA, INC. Proceeds from Sale of Available-for-sale Securities
CENCORA, INC. (COR) reported Proceeds from Sale of Available-for-sale Securities of $0 for the 6-month period ending 2018-03-31, per its 10-Q filed 2018-05-02.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities · last filed 2018-05-02
- CENCORA, INC. proceeds from sale of available-for-sale securities for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
- CENCORA, INC. proceeds from sale of available-for-sale securities for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- CENCORA, INC. proceeds from sale of available-for-sale securities for the quarter ending 2017-09-30 was $4.77M.
- CENCORA, INC. proceeds from sale of available-for-sale securities for the quarter ending 2017-06-30 was $33.88M, a 160.62% increase year-over-year.
- CENCORA, INC. proceeds from sale of available-for-sale securities for fiscal 2017 was $74.78M, a 26.57% decline from fiscal 2016.
- CENCORA, INC. proceeds from sale of available-for-sale securities for fiscal 2016 was $101.83M.
- CENCORA, INC. proceeds from sale of available-for-sale securities for fiscal 2015 was $0.00.
- CENCORA, INC. proceeds from sale of available-for-sale securities for fiscal 2014 was $0.00.
| Period end | Proceeds from Sale of Available-for-sale Securities 3 month | Proceeds from Sale of Available-for-sale Securities 6 month | Proceeds from Sale of Available-for-sale Securities 9 month | Proceeds from Sale of Available-for-sale Securities 12 month |
|---|---|---|---|---|
| 2018-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-02 | $0.00 10-Q · filed 2018-05-02 | $4.77M derived: sum of 3 quarters · filed 2018-05-02 | $38.65M derived: sum of 4 quarters · filed 2018-05-02 |
| 2017-12-31 | $0.00 10-Q · filed 2018-02-06 | $4.77M derived: sum of 2 quarters · filed 2018-02-06 | $38.65M derived: sum of 3 quarters · filed 2018-02-06 | $60.86M derived: sum of 4 quarters · filed 2018-05-02 |
| 2017-09-30 | $4.77M derived: 10-K 12 month − 10-Q 9 month · filed 2017-11-21 | $38.65M derived: sum of 2 quarters · filed 2017-11-21 | $60.86M derived: sum of 3 quarters · filed 2018-05-02 | $74.78M 10-K · filed 2017-11-21 |
| 2017-06-30 | $33.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-03 | $56.09M derived: sum of 2 quarters · filed 2018-05-02 | $70.01M 10-Q · filed 2017-08-03 | $70.01M derived: sum of 4 quarters · filed 2018-05-02 |
| 2017-03-31 | $22.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-02 | $36.13M 10-Q · filed 2018-05-02 | $36.13M derived: sum of 3 quarters · filed 2018-05-02 | $49.13M derived: sum of 4 quarters · filed 2018-05-02 |
| 2016-12-31 | $13.92M 10-Q · filed 2018-02-06 | $13.92M derived: sum of 2 quarters · filed 2018-02-06 | $26.92M derived: sum of 3 quarters · filed 2018-02-06 | $26.92M derived: sum of 4 quarters · filed 2018-02-06 |
| 2016-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-11-21 | $13.00M derived: sum of 2 quarters · filed 2017-11-21 | $13.00M derived: sum of 3 quarters · filed 2017-11-21 | $101.83M 10-K · filed 2017-11-21 |
| 2016-06-30 | $13.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-03 | $13.00M derived: sum of 2 quarters · filed 2017-08-03 | $101.83M 10-Q · filed 2017-08-03 | $101.83M derived: sum of 4 quarters · filed 2017-11-21 |
| 2016-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-04 | $88.83M 10-Q · filed 2017-05-04 | $88.83M derived: sum of 3 quarters · filed 2017-11-21 | $88.83M derived: sum of 4 quarters · filed 2017-11-21 |
| 2015-12-31 | $88.83M 10-Q · filed 2017-01-31 | $88.83M derived: sum of 2 quarters · filed 2017-11-21 | $88.83M derived: sum of 3 quarters · filed 2017-11-21 | $88.83M derived: sum of 4 quarters · filed 2017-11-21 |
| 2015-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-11-21 | $0.00 derived: sum of 2 quarters · filed 2017-11-21 | $0.00 derived: sum of 3 quarters · filed 2017-11-21 | $0.00 10-K · filed 2017-11-21 |
| 2015-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-02 | $0.00 derived: sum of 2 quarters · filed 2016-08-02 | $0.00 10-Q · filed 2016-08-02 | |
| 2015-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-05 | $0.00 10-Q · filed 2016-05-05 | ||
| 2014-12-31 | $0.00 10-Q · filed 2016-02-04 | |||
| 2014-09-30 | $0.00 10-K · filed 2016-11-22 | |||
| 2009-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2009-11-25 | $0.00 10-K · filed 2009-11-25 | ||
| 2009-06-30 | $0.00 10-Q · filed 2009-08-06 | |||
| 2008-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2010-11-23 | $1.38B 10-K · filed 2010-11-23 | ||
| 2008-06-30 | $1.38B 10-Q · filed 2009-08-06 | |||
| 2007-09-30 | $7.35B 10-K · filed 2009-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B |